Ambler, PA, United States of America

Robert A Galemmo, Jr


Average Co-Inventor Count = 4.6

ph-index = 12

Forward Citations = 755(Granted Patents)


Location History:

  • Lansdale, PA (US) (1990)
  • Ambler, PA (US) (1988 - 1992)
  • Collegeville, PA (US) (1993 - 2010)

Company Filing History:


Years Active: 1988-2010

Loading Chart...
27 patents (USPTO):Explore Patents

Title: Robert A. Galemmo, Jr.: Innovator in Pharmaceutical Patents

Introduction: Robert A. Galemmo, Jr. is a noteworthy inventor hailing from Ambler, Pennsylvania, with a portfolio of 27 patents primarily focused on advancements in pharmaceutical compositions. His innovative contributions have significant implications for the treatment of various cell proliferative disorders.

Latest Patents: Among his latest innovations, Robert has developed N-substituted tricyclic 3-aminopyrazoles which serve as inhibitors for the platelet-derived growth factor receptor (PDGF-R) kinase. This invention includes methods for the preparation of these derivatives, as well as pharmaceutical compositions that incorporate these compounds. The implications of this research may lead to groundbreaking treatments for tumors and other disorders characterized by excessive cell proliferation.

Career Highlights: Throughout his career, Robert A. Galemmo, Jr. has made substantial contributions to the pharmaceutical field. He has worked with reputable organizations, including Rorer Pharmaceutical Corporation and Rhône-Poulenc Rorer Pharmaceuticals Inc. His experience within these companies has shaped his ability to develop innovative solutions in drug design and development.

Collaborations: Collaboration has been an essential aspect of Robert's career. He has partnered with esteemed colleagues such as Henry F. Campbell and Fu-chi Huang, contributing to a wealth of knowledge and expertise that complements his innovations in pharmaceutical research and development.

Conclusion: Robert A. Galemmo, Jr. stands as an influential figure in the realm of pharmaceutical innovation. With a focus on the development of therapeutic agents for serious medical conditions, his work has the potential to transform treatment paradigms and improve patient outcomes. As he continues to innovate, the significance of his patents will likely extend into the future of medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…